TITLE:
      Alternate Day Buprenorphine Administration, Phase XI - 16
SUMMARY:
      The purpose of this study is to evaluate open buprenorphine dosing with dose choice after
      open exposure.
ELIGIBILITY CRITERIA:
      Please contact site for information.
